Autoimmune diseases represent a major health care problem and constitute the core of the clinical practice of Rheumatology. Although substantial progress has been made over the last decades, we still lack a precise understanding of the mechanisms responsible for the apparent failure of the immune system that results in autoimmunity. Recent advances in basic immunology, brought about the introduction into the field of the modern tools of molecular biology, have opened up new avenues to investigate autoimmunity. The overall objective of the research proposed in this Program Project is to investigate pathogenetic mechanisms of systemic autoimmune diseases and specifically rheumatologic diseases. To accomplish this goal the Program Project has been organized into five projects, supported by an administrative core unit. All five projects relate directly to the central theme of the research. Projects I and II focus on the autoantibody response in R.A. Collectively, they will investigate genetic and environmental factors underlying the sustained autoimmune response in this disease. Projects III and IV focus on mechanisms of abnormal T cell receptor repertoire development in animal models of autoimmunity. Project V will investigate contributions of the complement system to effector pathogenetic mechanisms of autoimmune diseases. Many collaborative arrangements have been established among the investigators of the five projects. Perhaps more important are the close conceptual relationships both explicit and implicit in the research proposed by the participating investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Program Projects (P01)
Project #
5P01AR003555-33
Application #
3092311
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1977-12-01
Project End
1996-02-28
Budget Start
1992-02-29
Budget End
1993-02-28
Support Year
33
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Rundle, C H; Schroeder Jr, H W; Koopman, W J (1998) In situ hybridization analysis of immunoglobulin heavy chain variable gene expression with family specific oligonucleotide probes. J Immunol Methods 218:31-52
Su, X; Zhou, T; Yang, P et al. (1998) Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor. Arthritis Rheum 41:139-49
Clausen, B E; Bridges Jr, S L; Lavelle, J C et al. (1998) Clonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synovium. Mol Med 4:240-57
Fleck, M; Zhou, T; Tatsuta, T et al. (1998) Fas/Fas ligand signaling during gestational T cell development. J Immunol 160:3766-75
Cheng, J; Liu, C; Yang, P et al. (1997) Increased lymphocyte apoptosis in Fas ligand transgenic mice. J Immunol 159:674-84
Johnson, M L; Keeton, L G; Zhu, Z B et al. (1997) Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID). Clin Exp Immunol 108:477-83
Hsu, H C; Zhou, T; Yang, P A et al. (1997) Increased acute-phase response and renal amyloidosis in aged CD2-fas-transgenic mice. J Immunol 158:5988-96
Zhou, T; Fleck, M; Mueller-Ladner, U et al. (1997) Kinetics of Fas-induced apoptosis in thymic organ culture. J Clin Immunol 17:74-84
Nishizaka, H; Horiuchi, T; Zhu, Z B et al. (1996) Genetic bases of human complement C7 deficiency. J Immunol 157:4239-43
Wu, J; Wilson, J; He, J et al. (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 98:1107-13

Showing the most recent 10 out of 105 publications